These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2833644)

  • 21. [Prognostic value of serum markers for liver fibrosis in transient abnormal myelopoiesis (TAM)].
    Kuroiwa Y; Suzuki N; Yamamoto M; Hatakeyama N; Hori T; Mizue N
    Rinsho Ketsueki; 2005 Nov; 46(11):1179-86. PubMed ID: 16440800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prenatal diagnosis of a transient myeloproliferative disorder in trisomy 21.
    Baschat AA; Wagner T; Malisius R; Gembruch U
    Prenat Diagn; 1998 Jul; 18(7):731-6. PubMed ID: 9706656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Osteopontin expression in the liver with severe perisinusoidal fibrosis: autopsy case of Down syndrome with transient myeloproliferative disorder.
    Tokairin T; Nishikawa Y; Watanabe H; Doi Y; Omori Y; Yoshioka T; Yamamoto Y; Yoshida M; Nishimura T; Li Q; Arai H; Ishida A; Takada G; Enomoto K
    Pathol Int; 2008 Jan; 58(1):64-8. PubMed ID: 18067644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Skin involvement in a newborn with down syndrome and transient myeloproliferative disorder.
    Natesirinilkul R; Charoenkwan P; Tantiprabha W; Pruksachartkun C; Ya-In C
    J Pediatr Hematol Oncol; 2012 May; 34(4):e171-2. PubMed ID: 22469947
    [No Abstract]   [Full Text] [Related]  

  • 25. Down syndrome and the myeloproliferative disorder.
    Amendola G; Amato L; Cirillo G; Dante G
    Clin Pediatr (Phila); 1990 Aug; 29(8):486. PubMed ID: 2145112
    [No Abstract]   [Full Text] [Related]  

  • 26. Transient myeloproliferative disorder in Down's syndrome.
    Kshirsagar VY; Ahmed M; Colaco SM; Ahmed M
    Indian J Pathol Microbiol; 2012; 55(3):426-7. PubMed ID: 23032858
    [No Abstract]   [Full Text] [Related]  

  • 27. A fetal case of transient abnormal myelopoiesis with severe liver failure in Down syndrome: prognostic value of serum markers.
    Shiozawa Y; Fujita H; Fujimura J; Suzuki K; Sato H; Saito M; Shimizu T; Yamashiro Y
    Pediatr Hematol Oncol; 2004; 21(3):273-8. PubMed ID: 15202167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An autopsy case of megakaryocytic myelosis.
    Iizumi T; Onishi Y; Higuchi M
    Acta Pathol Jpn; 1973 May; 23(2):367-83. PubMed ID: 4800539
    [No Abstract]   [Full Text] [Related]  

  • 29. Transient myeloproliferative disorder with erythroid differentiation in Down syndrome.
    Bozner P
    Arch Pathol Lab Med; 2002 Apr; 126(4):474-7. PubMed ID: 11900577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transient abnormal myelopoiesis in Down's syndrome.
    Kurahashi H; Hara J; Yumura-Yagi K; Tawa A; Kawa-Ha K
    Leuk Lymphoma; 1992 Dec; 8(6):465-75. PubMed ID: 1297480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Skin involvement in Down syndrome transient abnormal myelopoiesis.
    Krawczyk J; McDermott M; Irvine AD; O'Marcaigh A; Storey L; Smith O
    Br J Haematol; 2012 May; 157(3):280. PubMed ID: 22385123
    [No Abstract]   [Full Text] [Related]  

  • 32. Hydrops fetalis in a neonate with down syndrome, transient myeloproliferative disorder and hepatic fibrosis.
    Anuk D; Tarcan A; Alioglu B; Avci Z; Haberal N; Ozyurek E; Ozbek N
    Fetal Pediatr Pathol; 2007; 26(5-6):223-8. PubMed ID: 18363154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early down-regulation of Bcl-xL expression during megakaryocytic differentiation of thrombopoietin-induced CD34+ bone marrow cells in essential thrombocythemia.
    Zhang L; Zhao H; Sun A; Lu S; Liu B; Tang F; Feng Y; Zhao L; Yang R; Han ZC
    Haematologica; 2004 Oct; 89(10):1199-206. PubMed ID: 15477204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone marrow in megakaryocytic disorders.
    Burkhardt R
    Hematol Oncol Clin North Am; 1988 Dec; 2(4):695-733. PubMed ID: 3065325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet-derived growth factor may be associated with fibrosis in a Down syndrome patient with transient myeloproliferative disorder.
    Ogawa J; Kanegane H; Tsuneyama K; Kanezaki R; Futatani T; Nomura K; Ishizawa S; Sasahara M; Ito E; Miyawaki T
    Eur J Haematol; 2008 Jul; 81(1):58-64. PubMed ID: 18331602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Congenital transient myeloproliferative disorder progressing to acute myeloid leukemia in Down's syndrome: a case report.
    Prabhu PD; V G; Niveditha SR; Gayathri BR; Keshavamurthy SR
    Indian J Pathol Microbiol; 2004 Jan; 47(1):48-50. PubMed ID: 15471129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Transitory abnormal myelopoiesis of the monoblastic form in a newborn infant with Down's syndrome and liver cirrhosis].
    Urano Y; Kondo M; Hayashi Y; Wakuya J; Nakata T; Tanaka K; Seo A
    Ann Pathol; 1983 Dec; 3(4):337-9. PubMed ID: 6230084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Originalarbeiten.
    Queisser W; Weidenauer G; Queisser U; Kempgens U; Müller U
    Blut; 1976 Jan; 32(1):13-20. PubMed ID: 942869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transient myeloproliferative disorder in chromosomally normal newborn infant.
    Kalousek DK; Chan KW
    Med Pediatr Oncol; 1987; 15(1):38-41. PubMed ID: 2951583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet peroxidase-positive blast cells in transient myeloproliferative disorder with Down's syndrome.
    Suda J; Eguchi M; Ozawa T; Furukawa T; Hayashi Y; Kojima S; Maeda H; Tadokoro K; Sato Y; Miura Y
    Br J Haematol; 1988 Feb; 68(2):181-7. PubMed ID: 2964860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.